EUVIMEDEUVIMED entdecken
Crossref

Metabolic Stability and Comprehensive Metabolite Profiling of Chrysotobibenzyl in Human Liver Microsomes and Hepatocytes Employing UPLC‐MS/MS and UPLC‐Orbitrap‐HRMS Analysis

Xuanwei Liu, Junsheng Ge, Nana Zhao, Yeji Liang, Yu Liu, Xiaoman Wang, Lihua Tan iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Xuanwei Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Hepatocytes, Microsomes, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chrysotobibenzyl, a bioactive ingredient from Dendrobium chrysotoxum , exhibits potent anti‐tumor activity. However, its metabolic profiles remain unelucidated. This study aimed to disclose the metabolic fates of chrysotobibenzyl using human liver fractions. In vitro metabolism of chrysotobibenzyl was assessed using human liver microsomes and hepatocytes. The concentration of unchanged parent compound was quantified using a validated UPLC‐MS/MS method. Metabolite profiling was achieved by Q‐Exactive Orbitrap HRMS combined with Compound Discoverer software using a mass defect filtering approach, with structures characterized by accurate mass measurement and fragmentation pattern interpretation. Chrysotobibenzyl exhibited poor metabolic stability in human liver microsomes ( t 1/2 : 16.24 min) and hepatocytes ( t 1/2 : 44.35 min). Totally, 36 metabolites were identified, comprising 19 phase I metabolites, 10 glucuronide conjugates, and seven GSH adducts. Using reference standards, M22, M25, M27, and M28 were unambiguously identified as moscatilin, chrysotoxine, erianin, and crepidatin, respectively. The detection of GSH conjugates indicated the formation of reactive metabolites, including ortho ‐quinone and quinone‐methide intermediates. This study demonstrates the effectiveness of UPLC‐MS/MS and UPLC‐Orbitrap‐HRMS platforms for metabolic profiling. Metabolic pathways include demethylation, hydroxylation, dehydrogenation, glucuronidation, and GSH conjugation. These findings provide critical insights into the metabolism of chrysotobibenzyl in humans, enhancing our understanding of its biological activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryHepatocytesMicrosomes, LiverHumansChromatography, High Pressure LiquidReproducibility of ResultsMetabolomeLinear ModelsLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

chrysotobibenzyldendrobiummetabolic stabilitymetabolite characterization

Autor:innen und Institutionen

  • Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Department of Rehabilitation, Nan'ao People's Hospital, Shenzhen, China.
  • Acupuncture and Moxibustion Department, Luohu District Hospital of Traditional Chinese Medicine, Shenzhen, China.

ORCID-Profile: Lihua Tan

Zitieren

APA

Liu, X., Ge, J., Zhao, N., Liang, Y., Liu, Y., Wang, X., & Tan, L. (2025). Metabolic Stability and Comprehensive Metabolite Profiling of Chrysotobibenzyl in Human Liver Microsomes and Hepatocytes Employing UPLC‐MS/MS and UPLC‐Orbitrap‐HRMS Analysis. Biomedical Chromatography. https://doi.org/10.1002/bmc.70217

Vancouver

Liu X, Ge J, Zhao N, Liang Y, Liu Y, Wang X, et al. Metabolic Stability and Comprehensive Metabolite Profiling of Chrysotobibenzyl in Human Liver Microsomes and Hepatocytes Employing UPLC‐MS/MS and UPLC‐Orbitrap‐HRMS Analysis. Biomedical Chromatography. 2025. doi:10.1002/bmc.70217

BibTeX
@article{Liu2025,
  author = {Liu, Xuanwei and Ge, Junsheng and Zhao, Nana and Liang, Yeji and Liu, Yu and Wang, Xiaoman and Tan, Lihua},
  title = {Metabolic Stability and Comprehensive Metabolite Profiling of Chrysotobibenzyl in Human Liver Microsomes and Hepatocytes Employing UPLC‐MS/MS and UPLC‐Orbitrap‐HRMS Analysis},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70217}
}
Kostenlos starten →